---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013084"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:12:10.006033+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics shareholders approve 30M share increase and 1-for-2.5 to 1-for-10 reverse split

## Summary
- Stockholders elected directors Stroever, Angle, Gagnon, and Meikle; all received >90% of votes cast (excluding broker non-votes).
- Approved plan amendment increasing authorized shares by 30M to 30,629,489 for equity awards.
- Authorized board to implement reverse stock split in range of 1-for-2.5 to 1-for-10 at its discretion.
- Ratified Weinberg & Company as auditor for FY2025; advisory say-on-pay passed with 63% support.

## SEC filing metadata
- accession: 0001641172-25-013084
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000164117225013084/0001641172-25-013084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000164117225013084/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013084
- JSON: https://secwatch.observer/filing/0001641172-25-013084.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013084.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.